Targeted DNA mutagenesis for the cure of chronic viral infections
about
Towards a new era in medicine: therapeutic genome editingApplication of CRISPR/Cas9 Technology to HBVMicroRNAs as Important Players in Host-hepatitis B Virus InteractionsRecent advances in vaccine development for herpes simplex virus types I and IIGene therapy strategies for HIV/AIDS: preclinical modeling in humanized miceTargeted gene disruption to cure HIVPredictors of hepatitis B cure using gene therapy to deliver DNA cleavage enzymes: a mathematical modeling approachEngineering Plant Immunity: Using CRISPR/Cas9 to Generate Virus ResistanceNovel therapeutic approaches for hepatitis B virus covalently closed circular DNABacterial CRISPR/Cas DNA endonucleases: A revolutionary technology that could dramatically impact viral research and treatmentSustained Inhibition of HBV Replication In Vivo after Systemic Injection of AAVs Encoding Artificial Antiviral Primary MicroRNAs.In vivo dynamics of AAV-mediated gene delivery to sensory neurons of the trigeminal gangliaProgressive engineering of a homing endonuclease genome editing reagent for the murine X-linked immunodeficiency locus.Inhibition of hepatitis B virus replication by helper dependent adenoviral vectors expressing artificial anti-HBV pri-miRs from a liver-specific promoter.CRISPR/Cas9-mediated viral interference in plantsTALEN and CRISPR/Cas Genome Editing Systems: Tools of Discovery.Damaging the Integrated HIV Proviral DNA with TALENs.Genome editing and the next generation of antiviral therapy.In vivo disruption of latent HSV by designer endonuclease therapyGene- and protein-delivered zinc finger-staphylococcal nuclease hybrid for inhibition of DNA replication of human papillomavirus.Combinatorial anti-HIV gene therapy: using a multipronged approach to reach beyond HAARTAAV-mediated delivery of zinc finger nucleases targeting hepatitis B virus inhibits active replicationModel systems of motor neuron diseases as a platform for studying pathogenic mechanisms and searching for therapeutic agents.Genome editing strategies: potential tools for eradicating HIV-1/AIDS.Homing endonucleases: from genetic anomalies to programmable genomic clippersModulation of Gene Expression by Polymer Nanocapsule Delivery of DNA Cassettes Encoding Small RNAs.Targeting wild-type Erythrocyte receptors for Plasmodium falciparum and vivax Merozoites by Zinc Finger Nucleases In- silico: Towards a Genetic Vaccine against Malaria.Detection of treatment-resistant infectious HIV after genome-directed antiviral endonuclease therapy.Digital detection of endonuclease mediated gene disruption in the HIV provirus.The Structural Basis of Asymmetry in DNA Binding and Cleavage as Exhibited by the I-SmaMI LAGLIDADG Meganuclease.A curative regimen would decrease HIV prevalence but not HIV incidence unless targeted to an ART-naïve populationInactivation of hepatitis B virus replication in cultured cells and in vivo with engineered transcription activator-like effector nucleases.Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirsAn efficient antiviral strategy for targeting hepatitis B virus genome using transcription activator-like effector nucleases.In vitro Inactivation of Latent HSV by Targeted Mutagenesis Using an HSV-specific Homing EndonucleaseTAL effectors: highly adaptable phytobacterial virulence factors and readily engineered DNA-targeting proteinsRecent advances in developing nucleic acid-based HBV therapy.DNA cleavage enzymes for treatment of persistent viral infections: recent advances and the pathway forward.HIV-1 latency: an update of molecular mechanisms and therapeutic strategies.Towards an HBV cure: state-of-the-art and unresolved questions--report of the ANRS workshop on HBV cure.
P2860
Q26773287-B0E3236C-D27E-4DE8-9345-03ECF1308F03Q26779150-31387D98-0C4D-45FF-B8F2-1E713F15C960Q26781737-6170F4FC-40D9-44E0-A778-DC154D9B6B4CQ26859623-DACA635F-6FF5-4367-A499-3E039706A858Q27022347-116BBCC0-6429-4929-BD4D-6FB1E1D18081Q27023171-129DEE6B-619B-4107-8785-4B29063B732CQ27324340-36626DA7-E586-403C-B299-480BDB85ED0FQ28074250-E4E70CDA-F914-471F-8BDD-6AEB15DD9B0FQ28081274-C7664D25-A35A-406B-8869-9BD66ECF6350Q28087526-9FA8E670-4AE4-4DFB-821E-FBC421917727Q33635361-BB862392-E05B-428F-B376-1D9AFD0584A8Q33680976-FC2DE228-5C75-456B-BDE2-9BE9A8CEB9A1Q33698467-5D2D8302-C7C6-4ADC-B567-BD586FEE2459Q33791557-AE5A8FF8-F18A-41B9-A5F3-E41A49568E3EQ34045362-2F7EB29C-B14E-4AAC-BE6D-7F9C85E68729Q34394269-6D0BCBD8-59C5-4E91-86AE-A16E0DB5B6B8Q34475249-2F9005EF-0A18-4795-977C-039C2724E754Q34529971-B843138C-5917-4380-A750-C280706E79DEQ34540648-5B84DBDA-30B3-4AFE-BE47-FD1DE27B0C02Q34599142-13102701-FE95-4872-A0DF-B2D21DBD8366Q34647798-52AE4A48-633C-4169-B963-4E0F4BC9BA48Q35168444-CD1BF7F7-BA91-439E-96E5-D9B4DA3EAA01Q35540393-F6267021-E254-417B-B28F-43FC1DC8436EQ35612053-75844F33-D0F2-4521-9AA4-26687B261933Q35621488-D78F0651-FF26-415A-92E3-17604101578EQ35650064-1464FC24-9E00-4E9D-8E75-854B331DDFF7Q36405378-EBD47B6D-B9FA-48A5-BB2A-6C699D91E7EEQ36494284-344AACCD-A730-4D93-A2A5-0E2FE47802B7Q36528328-E9F7926E-B8D5-426A-A401-00780FC1506FQ36567836-0AF6F596-3F4B-4AFF-9171-80DFA12EAA85Q36611180-2BC30E8C-7D78-4C00-A258-53786C03FF9FQ37254885-DDD5CEFA-08DC-48FC-8D76-CED9607DB5CBQ37273652-2A0AA301-A7E2-4E08-BEF6-6F405497EEC0Q37562042-955C481C-E7DE-4EE1-BD7C-1218C394C96DQ37634060-E0C34393-1B75-4DFE-BBC4-D771E83B34A1Q38109405-B9054FDE-42EF-4FBC-9601-6471EAEA579DQ38160538-DE4C37CF-7039-41BD-BEC5-95D86529A4D1Q38184158-EB84A5EF-DE50-4975-8195-20FE0FEE97E9Q38204866-DAED9225-98F2-47B6-9839-F9AEDB59CDB5Q38351585-7A7FD92E-932F-4D2C-A63E-5B7B30C45BBB
P2860
Targeted DNA mutagenesis for the cure of chronic viral infections
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Targeted DNA mutagenesis for the cure of chronic viral infections
@ast
Targeted DNA mutagenesis for the cure of chronic viral infections
@en
Targeted DNA mutagenesis for the cure of chronic viral infections
@nl
type
label
Targeted DNA mutagenesis for the cure of chronic viral infections
@ast
Targeted DNA mutagenesis for the cure of chronic viral infections
@en
Targeted DNA mutagenesis for the cure of chronic viral infections
@nl
prefLabel
Targeted DNA mutagenesis for the cure of chronic viral infections
@ast
Targeted DNA mutagenesis for the cure of chronic viral infections
@en
Targeted DNA mutagenesis for the cure of chronic viral infections
@nl
P2093
P2860
P3181
P356
P1433
P1476
Targeted DNA mutagenesis for the cure of chronic viral infections
@en
P2093
Daniel Stone
Esther Mintzer
Joshua T Schiffer
Keith R Jerome
Martine Aubert
Nicholas D Weber
P2860
P304
P3181
P356
10.1128/JVI.00052-12
P407
P577
2012-09-01T00:00:00Z